Status:
COMPLETED
Observational Study of Vision Improvement in Late Stage Dry AMD Patients
Lead Sponsor:
Optimal Acuity Corporation
Collaborating Sponsors:
Bochner Eye Institute
Conditions:
Dry Age-related Macular Degeneration
Eligibility:
All Genders
50-100 years
Brief Summary
The purpose of this study is to assess the vision improvement achieved by patients with late stage dry age-related macular degeneration who received corneal treatments by a low vision aid device.
Detailed Description
The purpose of this study is to assess the vision improvement achieved by patients with late stage dry age-related macular degeneration who received corneal treatments by a low vision aid device. Pati...
Eligibility Criteria
Inclusion
- \- Male or female
- \- Any race
- \- Patient is at least 50 years old
- \- Patient has diagnosed late stage dry age-related macular degeneration in one or both eyes.
- \- Treated eyes were pseudophakic at the time of treatment.
- \- Patient had moderate to severe baseline vision impairment with best spectacle-corrected distance visual acuity (CDVA) of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s).
- \- Patient CDVA records are available at baseline and at 12 month post-treatment.
Exclusion
- \- Corneal disease or disorder in either eye.
- \- Increased intraocular pressure (above 20 mm Hg), glaucoma or history of glaucoma.
- \- Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study.
- \-
Key Trial Info
Start Date :
August 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04349254
Start Date
August 14 2020
End Date
December 31 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bochner Eye Institute
Toronto, Ontario, Canada, M5R 1A9